オクレリズマブ (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "オクレリズマブ" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

5,225^th place

low place

low place

low place

2^nd place

6^th place

low place

clinicaltrials.gov

臨床試験番号 NCT00539838 研究名 "A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)" - ClinicalTrials.govClinicalTrials.gov
臨床試験番号 NCT00676715 研究名 "A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis" - ClinicalTrials.govClinicalTrials.gov

Kausar, F (2009). “Ocrelizumab: a step forward in the evolution of B-cell therapy”. Expert opinion on biological therapy 9 (7): 889–95. doi:10.1517/14712590903018837. PMID 19463076.

Kausar, F (2009). “Ocrelizumab: a step forward in the evolution of B-cell therapy”. Expert opinion on biological therapy 9 (7): 889–95. doi:10.1517/14712590903018837. PMID 19463076.
Hutas, G (2008). “Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies”. Current opinion in investigational drugs (London, England : 2000) 9 (11): 1206–15. PMID 18951300.

臨床試験番号 NCT00539838 研究名 "A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)" - ClinicalTrials.govClinicalTrials.gov
臨床試験番号 NCT00676715 研究名 "A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis" - ClinicalTrials.govClinicalTrials.gov